Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Novartis AG (NYSE:NVS)

70.43
Delayed Data
As of Jan 19
 -1.46 / -2.03%
Today’s Change
66.93
Today|||52-Week Range
83.58
-3.31%
Year-to-Date
Mallinckrodt Hit With $100M Fine for Squelching Rival to Infant Seizure Drug
Jan 18 / TheStreet.com - Paid Partner Content
Lilly Wins Appeal Against Teva in Alimta Patent Lawsuit
Jan 13 / Zacks.com - Paid Partner Content
Watch Point Trust Co Buys Comcast Corp, Newell Brands Inc, Novartis AG, Sells Abbott ...
Jan 18 / GuruFocus News - Paid Partner Content
3 Surprises From Pfizer at the J. P. Morgan Healthcare Conference
Jan 11 / MotleyFool.com - Paid Partner Content
Why Bristol-Myers Squibb May Be a Merger Target Soon
Jan 17 / TheStreet.com - Paid Partner Content
Why Novartis Dropped 15.1% in 2016
Jan 11 / MotleyFool.com - Paid Partner Content
Novartis to Conduct Trial on Obese, Type II Diabetes Patients
Jan 13 / Zacks.com - Paid Partner Content
The 1 Biotech Stock I Want to Own in 2017
Jan 11 / MotleyFool.com - Paid Partner Content
Why Juno Therapeutics Crashed 57.1% in 2016 and What's Next
Jan 13 / MotleyFool.com - Paid Partner Content
Ionis, Novartis Ink Deal to Focus on Cardiovascular Treatments
Jan 09 / Zacks.com - Paid Partner Content
4 Signs Glaxo's Turnaround Is Taking Hold
Jan 13 / MotleyFool.com - Paid Partner Content
Teva Falls on Disappointing 2017 Sales & Earnings Guidance
Jan 09 / Zacks.com - Paid Partner Content
ARIAD: Acquisition by Takeda Bodes Well, Competition a Risk
Jan 13 / Zacks.com - Paid Partner Content
Momenta (MNTA) to Receive $50M Under CSL Collaboration
Jan 06 / Zacks.com - Paid Partner Content
Short Interest In Conatus Pharmaceuticals Surges
Jan 13 / Benzinga - Paid Partner Content
Roche's (RHHBY) Lucentis Gets FDA Nod for Fifth Indication
Jan 06 / Zacks.com - Paid Partner Content